Tibsovo is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Agios Pharmaceuticals, Inc.. The primary component is Ivosidenib.
| Product ID | 71334-100_05b9d296-44dd-4ee6-9702-84d3b2c263d6 |
| NDC | 71334-100 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tibsovo |
| Generic Name | Ivosidenib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-07-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA211192 |
| Labeler Name | Agios Pharmaceuticals, Inc. |
| Substance Name | IVOSIDENIB |
| Active Ingredient Strength | 250 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2018-07-20 |
| Marketing End Date | 2024-11-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA211192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-07-20 |
| Ingredient | Strength |
|---|---|
| IVOSIDENIB | 250 mg/1 |
| SPL SET ID: | 5b6d8ae8-bac8-4e1b-b1b4-7f9665e62de5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 71334-100 | Tibsovo | ivosidenib |
| 72694-617 | TIBSOVO | ivosidenib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TIBSOVO 87556035 5587521 Live/Registered |
Agios Pharmaceuticals, Inc. 2017-08-04 |
![]() TIBSOVO 87556017 5587520 Live/Registered |
Agios Pharmaceuticals, Inc. 2017-08-04 |
![]() TIBSOVO 87122179 5444093 Live/Registered |
Agios Pharmaceuticals, Inc. 2016-07-31 |